1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €3.72 (-84.85%). The median is €3.43 (-86.03%).
| Buy |
9 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 6.9M | 175.39% |
| Gross profit | 6.87M | 174.13% |
| Net profit | -134.12M | 1,763.72% |
| EBITDA | -76.84M | 1,085.28% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €62.64M |
Number of shares | 2.63M |
52-week high/low | €39.07 - €4.28 |
| Dividends | No |
Beta | 2.47 |
P/E ratio | -1.03 |
PEG ratio | 0.00 |
P/B ratio | 76.20 |
P/S ratio | 1.94 |
Company profile
| Name | Cue Biopharma Inc |
| CEO | Shao-Lee Lin |
| Employees | 29 |
Discover assets
Shareholders of Cue Biopharma Inc also invest in the following assets
